Explore the inspiring world of Omics with "OMG OMx," a Bruker podcast. Each episode features an expert in mass spectrometry, delving into their career and the OMG moments that shaped their passion for science. Discover personal stories and unique approaches to Omics research, and get inspired by the human side of scientific innovation.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
omg OMx Podcast
Claim This Podcastby Azo Network
11 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇬🇧
Podcast Overview
Explore the inspiring world of Omics with "OMG OMx," a Bruker podcast. Each episode features an expert in mass spectrometry, delving into their career and the OMG moments that shaped their passion for science. Discover personal stories and unique approaches to Omics research, and get inspired by the human side of scientific innovation.<hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
11/30/2023
1 verified contact email on file for omg OMx Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
February 1, 2024
Decoding the Brain: Omics in Neuroscience
<p>A new year, a new episode!</p><br><p>In this episode, Sapient’s Tanya Nguen joins us to bring a unique perspective that transcends traditional boundaries, offering valuable insights into treating clinical human diseases. Tanya Nguyen shares insights from her college research in neuroscience, exploring the formative years that shaped her journey. Discover the profound influence of clinical experiences on Tanya's approach to research and how Sapient has provided the opportunity to contribute to science at various stages of drug development.</p><br><p>0:51: The transition from a "non-Omics" background to shaping the future of clinical disease treatment</p><p>2:19: Impact of her college research in neuroscience during her formative years</p><p>6:13: Connecting research and clinical outcomes: Sapient's role in all stages of drug development </p><p>7:29: Tanya shares her "OMG moment" that set her on the path of scientific exploration</p><p>9:02: Significant of mass spectrometry on in the broad Omics field, spanning from early-stage discovery to patient-oriented applications</p><p>10:51 - The pivotal role Omics plays at Sapient and the exciting metrics and stats the organization utilizes</p><p>13:06 - The future of Omics at Sapient, focusing on ramping up metabolomics, lipidomics, and proteomics to make a lasting impact beyond the genome</p><p>18:05 - A glimpse into a day at Sapient and the unique Sapient approach</p><p>19:39 🍹 Bonus Content: Discover Tanya’s hobby outside the lab</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
January 25, 2024
When Mass Spectrometry Redefines the Pharma Industry
<p>2023: Mike Greig's Journey from Chemistry to Mass Spec Magic (omgOMX Finale!)</p><p>Thank you for joining us for an exciting year of omgOMX! We're wrapping up 2023 with Bruker's Pharma Biopharma lead, Mike Greig, who shares his incredible journey from a chemistry major to the world of mass spec. </p><br><p>Join us as he reminisces on:</p><p>00:28: Early Days: From polymers (nail polish anyone?) to discovering the magic of mass spec in the pharma industry </p><p>04:39: Influential People: Those who shaped his career and inspired him along the way </p><p>06:47: Mike's OMG Moment: A candied story just in time for Christmas! </p><p>08:07: Drug Discovery Advancements: A glimpse into the ever-evolving landscape </p><p>10:17: The Drug Discovery Pipeline: How it has transformed over time </p><p>12:48: Mass Spec's Crucial Role: How this technology drives innovation in drug discovery </p><p>14:41: Challenges and Solutions: Overcoming obstacles in the pharma biopharma industry </p><p>16:31: Mass Spec Innovation Pipeline: A peek into the future of this powerful technology </p><p>18:42: Getting Up and Running: How mass spec companies help researchers and scientists succeed </p><p>20:29: The Sports Influence: An unexpected connection that inspires </p><br><p>Don't miss this special episode packed with insights and inspiration!</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
January 18, 2024
Immunopeptidomics Offer New Hope in Cancer Research
<p>In this episode of omgOMX, enter the world of immunopeptidomics with University of Oxford’s Associate Prof. Nicola Ternette. Nicola shares her humble beginnings in virology to becoming a leading expert in the field of immunology. Discover how mass spectrometry opened new doors for protein analysis and vaccine development how Nicola's lab is revolutionizing cancer therapy by profiling immune molecules in different diseases, and how this information can be used to direct clinical applications</p><br><p>Don't miss this inspiring episode that showcases the power of women in science and the potential of immunopeptidomics to shape the future of cancer therapies. Hit that subscribe button and share this episode with fellow science enthusiasts!</p><br><p>00:21 - Nicola's humble beginnings in virology, shaping her path to where she is today</p><p>05:48 - Moving to the UK and her exposure to mass spectrometry at Benedict Kessler's proteomics facility</p><p>07:43 - Working on HIV vaccines with experts to understand how infected cells appear to the immune system</p><p>09:02 - Specializing in profiling immune molecules in diseases and cancer to inform vaccine development</p><p>10:00 - The breakthrough realization of applying immune system knowledge to cancer research</p><p>10:18 - Focusing on mechanistic research and profiling specific antigens for potential clinical applications</p><p>11:29 - Collaboration with industry for cancer therapies and the importance of automation in research</p><p>13:09 - Automating the process for analyzing broader sample cohorts and optimizing sample acquisition</p><p>14:42 - The challenge of high-throughput analysis and the future of immunopeptidomics</p><p>16:38 - The significance of validation in mass spectrometry workflows and antigen identification</p><p>21:15 - The impact of the pandemic on vaccine research and its role in cancer therapy</p><p>23:53 - Optimism about future advancements in immunopeptidomics and cancer immunotherapy</p><p>27:56 - Surprising discoveries and expanding collaborations in industry and clinical partnerships</p><p>30:32 - Balancing personal and professional life as an academic researcher</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
11 total episodes available
Deep-dive analytics for omg OMx Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is omg OMx Podcast?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 7 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.